Scilex Settles Debt, Expands Distribution of Non-Opioid Treatments
Company Announcements

Scilex Settles Debt, Expands Distribution of Non-Opioid Treatments

Scilex Holding Company ( (SCLX) ) has issued an update.

Scilex Holding Company has reached an agreement with Endeavor Distribution LLC to satisfy a $10 million loan from FSF 33433 LLC by delivering a specified quantity of their ZTlido product. This agreement not only settles the debt but further strengthens Scilex’s partnership with Endeavor, which will distribute Scilex’s non-opioid pain management products across the U.S., potentially expanding their market reach. The deal underlines Scilex’s commitment to increasing access to their non-opioid treatments, a move that is expected to benefit thousands of patients suffering from acute and chronic pain.

See more insights into SCLX stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyScilex announces the continuing support from Endeavor Distribution
TheFlyScilex recieved the Drug Distributor Accredidation from NABP
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App